Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinska AkadfiledCriticalMedizinska Akad
Priority to BG9375191ApriorityCriticalpatent/BG51002A1/en
Publication of BG51002A1publicationCriticalpatent/BG51002A1/en
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
The method is applicable in the antigen analysis. It allows to quickly and easily produce a large amount of highly active and monospecific antibodies, which impacts on the high precision of salmonellas and other microorganisms' antigen analysis, as well as on the differentiation of serogroup A of Candida albicans. This method is used to create hybridoma cell lines - producers of the monoclonal antibody, which are registered in the National Bank for Industrial Microorganisms and Cell Cultures (NBIMCC) under No. 1870 and 1871.
BG9375191A1991-01-301991-01-30Method for the preparation of monoclonal antibody against 03- salmonellan antigen
BG51002A1
(en)
Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application
Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
MONOCLONAL ANTIBODY SPECIFIC FOR A SURFACE ANTIGEN OF ACTIVATED B CELLS AND / OR T CELLS TRANSFORMED BY HTLV-I, A LINE OF HYBRIDOMA CELLS PRODUCING THIS ANTIBODY, METHOD FOR THE DETECTION OF HTL TRANSFORMED T CELLS AND / OR ACTIVATED B CELLS